Protogenix
PrivateLast Round
Accelerator
Feb 8, 2023
Total Funding Raised
$250,000
Company Overview
Protogenix operates in Healthcare & Life Sciences and is based in Ithaca, New York. Its latest recorded funding round was an Accelerator round in February 2023.
Protogenix is a biotechnology company that develops a plant-based molecular farming platform to produce complex animal proteins for food and pharmaceutical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protogenix Comparables
Compare Protogenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bright Biotech | 79% | |
| Seedling Biosystems Inc. | 78% | |
| Ergo Bioscience | 77% |
For institutional investors. Book with your work email.
Protogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 8, 2023 | ||||
| Accelerator | Jan 23, 2023 |
For institutional investors. Book with your work email.
Protogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IndieBio | Accelerator |
| Kevin M. McGovern Family Center for Venture Development in the Life Sciences | Accelerator |
| SOSV | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2023
Received funding from Kevin M. McGovern Family Center for Venture Development.
For institutional investors. Book with your work email.
Protogenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Protogenix's valuation, stock price, and market status.
Is Protogenix a public or private company?
Protogenix is a private company.
What is the current stock price of Protogenix?
Protogenix is a private company, so its shares have no public market price. Caplight tracks Protogenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Protogenix worth (valuation)?
Valuation information for Protogenix is not publicly available.
Can I buy Protogenix stock?
Protogenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Protogenix's last funding round?
Protogenix's most recent funding round was Accelerator on February 8, 2023.
Who are the main investors in Protogenix?
Key investors in Protogenix include IndieBio.
Will Protogenix IPO soon?
No public IPO plans have been announced for Protogenix.
How can I track Protogenix secondary market activity?
Caplight tracks bids, offers, and trades in Protogenix's shares on secondary markets.